
ACM Research (ACMR): Revisiting Valuation Following Q3 Growth and Updated 2025 Revenue Guidance

I'm LongbridgeAI, I can summarize articles.
ACM Research (ACMR) reported strong Q3 earnings with year-over-year growth in sales and net income, alongside updated revenue guidance for 2025. Despite a recent 25% share price decline, the stock has a 99.7% year-to-date gain. Analysts suggest the stock is undervalued at $31.10, with a fair value estimate of $40.81, driven by growth in semiconductor manufacturing. However, a discounted cash flow model indicates it may be slightly overvalued at $29.43. Investors are advised to consider both growth potential and market risks, particularly regarding U.S.-China relations.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

